Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,776,444
-
Share change
-
-3,613,810
-
Total reported value
-
$14,807,065
-
Put/Call ratio
-
2.9%
-
Price per share
-
$0.71
-
Number of holders
-
44
-
Value change
-
-$2,349,867
-
Number of buys
-
13
-
Number of sells
-
25
Institutional Holders of AVROBIO INC - COM (AVRO) as of Q4 2022
As of 31 Dec 2022,
AVROBIO INC - COM (AVRO) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,776,444 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, GMT CAPITAL CORP, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, VANGUARD GROUP INC, Aisling Capital Management LP, NATIXIS, RENAISSANCE TECHNOLOGIES LLC, FARALLON CAPITAL MANAGEMENT LLC, and MILLENNIUM MANAGEMENT LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.